Hydrogen peroxide as a paracrine vascular mediator: Regulation and signaling leading to dysfunction

Experimental Biology and Medicine

Volumn 231, Issue 3, 2006, Pages 237-251

  Ardanaz, Noelia ^a   Pagano, Patrick J ^a,b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Blood vessel; Hydrogen peroxide; Hypertension; Hypertrophy; Reactive oxygen species; Signaling

Indexed keywords

CALCIUM; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDOREDUCTASE; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO KINASE; SCAVENGER; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; VASOACTIVE AGENT;

ADVENTITIA; ANGIOGENESIS; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CALCIUM TRANSPORT; ENZYME ACTIVITY; HUMAN; HYPERTROPHY; MUSCLE HYPERTROPHY; NONHUMAN; PROTEIN FUNCTION; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 33644681926     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020623100302     Document Type: Short Survey

References (206)

1. Schubert J, Wilmer JW. Does hydrogen peroxide exist "free" in biological systems? Free Radic Biol Med 11:545-555, 1991.
2. Ruef J, Rao GN, Li F, Bode C, Patterson C, Bhatnagar A, Runge MS. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation 97:1071-1078, 1998.
3. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148, 1994.
4. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923, 1996.
5. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity. Upstream mediators. Circ Res 91:406-413, 2002.
6. Griendling KK, Sorescu D, Lassègue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20:2175-2183, 2000.
7. Touyz RM, Schiffrin EL. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 34:976-982, 1999.
8. Touyz RM, Yao G, Schiffrin EL. c-Src induces phosphorylation and translocation of P47phox. Role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23:981-987, 2003.
9. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, Schiffrin EL. Expression of a functionally active Gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries. Regulation by angiotensin II. Circ Res 90:1205-1213, 2002.
10. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52:639-672, 2000.
11. Mohazzab-H KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 266:H2568-H2572, 1994.
12. Mohazzab-H KM, Wolin MS. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle. Am J Physiol 267:L815-L822, 1994.
13. Pagano PJ, Ito Y, Tornheim K, Gallop PM, Tauber AI, Cohen RA. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol 268:H2274-H2280, 1995.
14. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A 94:14483-14488, 1997.
15. Sorescu D, Weiss D, Lassègue B, Clempus RE, Szöcs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105:1429-1435, 2002.
16. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. P22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271:23317-23321, 1996.
17. Lavigne MC, Malech HL, Holland SM, Leto TL. Genetic demonstration of P47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 104:79-84, 2001.
18. phox may participate in forming this oxidase in vitro and in vivo. J Biol Chem 274:19814-19822, 1999.
19. Suh Y-A, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox1 (letter). Nature 401:79-82, 1999.
20. phox homologues in vascular smooth muscle cells. Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88:888-894, 2001.
21. Jones SA, O'Donnell VB, Wood JD, Broughton JP, Hughes EJ, Jones OTG. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 271:H1626-H1634, 1996.
22. Meyer JW, Holland JA, Ziegler LM, Chang M-M, Beebe G, Schmitt ME. Identification of a functional leukocyte-type NADPH oxidase in human endothelial cells: a potential atherogenic source of reactive oxygen species. Endothelium 7:11-22, 1999.
23. Smith KR, Klei LR, Barchowsky A. Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 280:L442-L449, 2001.
24. phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem 278:47291-47298, 2003.
25. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109:227-233, 2004.
26. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor B1. J Biol Chem 270:30334-30338, 1995.
27. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest 89:1006-1013, 1992.
28. Geiszt M, Witta J, Baffi J, Lekstrom K, Leto TL. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J 17:1502-1504, 2003.
29. 2 and plays an integral role in insulin signal transduction. Mol Cell Biol 24:1844-1854, 2004.
30. Fukui T, Lassegue B, Kai H, Alexander RW, Griendling KK. Cytochrome B-558 α-subunit cloning and expression in rat aortic smooth muscle cells. Biochim Biophys Acta 1231:215-219, 1995.
31. Wang HD, Hope S, Du Y, Quinn MT, Cayatte A, Pagano PJ, Cohen RA. Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. Hypertension 33:1225-1232, 1999.
32. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q IV, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK. P22phox MRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80:45-51, 1997.
33. Jones SA, Wood JD, Coffey MJ, Jones OTG. The functional expression of P47-Phox and P67-Phox may contribute to the generation of superoxide by an NADPH oxidase-like system in human fibroblasts. FEBS Lett 355:178-182, 1994.
34. phox MRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension 32:331-337, 1998.
35. phox in aortas from angiotensin II-infused mice. Am J Physiol Heart Circ Physiol 279:H2234-H2240, 2000.
36. Görlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A Gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87:26-32, 2000.
37. Bayraktutan U, Blayney L, Shah AM. Molecular characterization and localization of the NAD(P)H oxidase components Gp91-Phox and P22-Phox in endothelial cells. Arterioscler Thromb Vasc Biol 20:1903-1911, 2000.
38. Sorescu GP, Song H, Tressel SL, Hwang J, Dikalov S, Smith DA, Boyd NL, Platt MO, Lassègue B, Griendling KK, Jo H. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ Res 95:773-779, 2004.
39. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111:1201-1209, 2003.
40. Cosentino F, Barker JE, Brand MP, Heales SJ, Werner ER, Tippins JR, West N, Channon KM, Volpe M, Luscher TF. Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice. Arterioscler Thromb Vasc Biol 21:496-502, 2001.
41. 2 sensor in rat pulmonary vasculature. Circ Res 73:1100-1112, 1993.
42. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 191:421-427, 1980.
43. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278:36027-36031, 2003.
44. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes H-P, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage (letter). Nature 404:787-790, 2000.
45. Yamagishi S, Edelstein D, Du X, Kaneda Y, Guzmán M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 276:25096-25100, 2001.
46. Zweier JL, Broderick R, Kuppusamy P, Thompson-Gorman S, Lutty GA. Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation. J Biol Chem 269:24156-24162, 1994.
47. Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555:589-606, 2004.
48. Rieger JM, Shah AR, Gidday JM. Ischemia-reperfusion injury of retinal endothelium by cyclooxygenase- and xanthine oxidase-derived superoxide. Exp Eye Res 74:493-501, 2002.
49. McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, Jo H, Harrison DG. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 285:H2290-H2297, 2003.
50. Ohtsubo T, Rovira II, Starost MF, Liu C, Finkel T. Xanthine oxidoreductase is an endogenous regulator of cyclooxygenase-2. Circ Res 95:1118-1124, 2004.
51. Kukreja RC, Kontos HA, Hess ML, Ellis EF. PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res 59:612-619, 1986.
52. Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes RP, Busse R. Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 88:44-51, 2001.
53. Marklund SL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 222:649-655, 1984.
54. Jung O, Marklund SL, Geiger H, Pedrazzini T, Busse R, Brandes RP. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability. In vivo and ex vivo evidence from EcSOD-deficient mice. Circ Res 93:622-629, 2003.
55. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33:337-349, 2002.
56. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of nox1 and nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24:677-683, 2004.
57. Stralin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 15:2032-2036, 1995.
58. phox. Circulation 106:2497-2502, 2002.
59. Zhang H, Schmeisser A, Garlichs CD, Plotze K, Damme U, Mugge A, Daniel WG. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res 44:215-222, 1999.
60. Marklund SL. Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J Biol Chem 267:6696-6701, 1992.
61. Fukai T, Siegfried MR, Ushio-Fukai M, Griendling KK, Harrison DG. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res 85:23-28, 1999.
62. Aruoma OI, Halliwell B. Molecular Biology of Free Radicals in Human Diseases. London: OICA International, 1998.
63. Suttorp N, Toepfer W, Roka L. Antioxidant defense mechanisms of endothelial cells: glutathione redox cycle versus catalase. Am J Physiol 251:C671-C680, 1986.
64. Ursini F, Maiorino M, Brigelius-Flohé R, Aumann KD, Roveri A, Schomburg D, Flohé L. Diversity of glutathione peroxidases. Methods Enzymol 252:38-53, 1995.
65. Harlan JM, Levine JD, Callahan KS, Schwartz BR. Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. J Clin Invest 73:706-713, 1984.
66. Demaree SR, Lawler JM, Linehan J, Delp MD. Ageing alters aortic antioxidant enzyme activities in Fischer-344 rats. Acta Physiol Scand 166:203-208, 1999.
67. Uddin M, Yang H, Shi M, Polley-Mandal M, Guo Z. Elevation of oxidative stress in the aorta of genetically hypertensive mice. Mech Ageing Dev 124:811-817, 2003.
68. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schönbein GW, Parmer RJ. Plasma hydrogen peroxide production in human essential hypertension. Role of heredity, gender, and ethnicity. Hypertension 36:878-884, 2000.
69. Lacy F, O'Connor DT, Schmid-Schönbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 16:291-303, 1998.
70. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38:1543-1552, 2005.
71. Dubuisson M, Vander Stricht D, Clippe A, Etienne F, Nauser T, Kissner R, Koppenol WH, Rees JF, Knoops B. Human peroxiredoxin 5 is a peroxynitrite reductase. FEBS Lett 571:161-165, 2004.
72. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 273:6297-6302, 1998.
73. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, Kang SW. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435:347-353, 2005.
74. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 70:593-599, 1992.
75. Burke-Wolin TM, Abate CJ, Wolin MS, Gurtner GH. Hydrogen peroxide-induced pulmonary vasodilation: role of guanosine 3′, 5′-cyclic monophosphate. Am J Physiol 5:L393-L398, 1991.
76. Fujimoto S, Asano T, Sakai M, Sakurai K, Takagi D, Yoshimoto N, Itoh T. Mechanisms of hydrogen peroxide-induced relaxation in rabbit mesenteric small artery. Eur J Pharmacol 412:291-300, 2001.
77. Yang Z, Zhang A, Altura BT, Altura BM. Endothelium-dependent relaxation to hydrogen peroxide in canine basilar artery: a potential new cerebral dilator mechanism. Brain Res Bull 47:257-263, 1998.
78. 2 in rat aorta. Vascul Pharmacol 43:128-138, 2005.
79. Yang Z, Zheng T, Zhang A, Altura BT, Altura BM. Mechanisms of hydrogen peroxide-induced contraction of rat aorta. Eur J Pharmacol 344:169-181, 1998.
80. Rodriguez-Martinez MA, Garcia-Cohen EC, Baena AB, Gonzalez R, Salaices M, Marin J. Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. B J Pharmacol 125:1329-1335, 1998.
81. 2-evoked contraction in the isolated rat aorta. Gen Pharmacol 31:115-119, 1998.
82. Gao YJ, Lee RM. Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. Br J Pharmacol 134:1639-1646, 2001.
83. 2-induced contraction in pulmonary artery. Am J Physiol 272:H2686-H2692, 1997.
84. 20 phosphorylation- independent contraction in intact and permeabilized vascular muscle. Am J Physiol Heart Circ Physiol 279:H1185-H1193, 2000.
85. 2-induced arterial muscle contraction. Am J Physiol Heart Circ Physiol 279:H1194-H1200, 2000.
86. Yang ZW, Zheng T, Wang J, Zhang A, Altura BT, Altura BM. Hydrogen peroxide induces contraction and raises [Ca2+]i in canine cerebral arterial smooth muscle: participation of cellular signaling pathways. Naunyn Schmiedebergs Arch Pharmacol 360:646-653, 1999.
87. Horowitz A, Menice CB, Laporte R, Morgan KG. Mechanisms of smooth muscle contraction. Physiol Rev. 76:967-1003, 1996.
88. Tabet F, Savoia C, Schiffrin EL, Touyz RM. Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 44:200-208, 2004.
89. Favero TG, Zable AC, Abramson JJ. Hydrogen peroxide stimulates the Ca2+ release channel from skeletal muscle sarcoplasmic reticulum. J Biol Chem 270:25557-25563, 1995.
90. Grover AK, Samson SE, Fomin VP. Peroxide inactivates calcium pumps in pig coronary artery. Am J Physiol 263:H537-H543, 1992.
91. 2+ pumps of coronary artery. Am J Physiol 255:C297-C303, 1988.
92. 2-induced contractions of pulmonary arteries. Am J Physiol 264:H1542-H1547, 1993.
93. 2-induced contraction of rat aorta. Acta Pharmacol Sin 22:498-504, 2001.
94. Suzuki YJ, Ford GD. Inhibition of Ca(2+)-ATPase of vascular smooth muscle sarcoplasmic reticulum by reactive oxygen intermediates. Am J Physiol 261:H568-H574, 1991.
95. Redondo PC, Salido GM, Rosado JA, Pariente JA. Effect of hydrogen peroxide on Ca2+ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms. Biochem Pharmacol 67:491-502, 2004.
96. 2-mediated Ca2+ release from pulmonary smooth muscle mitochondria. Mol Cell Biochem 159:95-103, 1996.
97. Oeckler RA, Kaminski PM, Wolin MS. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res 92:23-31, 2003.
98. Oeckler RA, Arcuino E, Ahmad M, Olson SC, Wolin MS. Cytosolic NADH redox and thiol oxidation regulate pulmonary arterial force through ERK MAP kinase. Am J Physiol Lung Cell Mol Physiol 288:L1017-L1025, 2005.
99. Thakali K, Demel SL, Fink GD, Watts SW. Endothelin-1-induced contraction in veins is independent of hydrogen peroxide. Am J Physiol Heart Circ Physiol 289:H1115-H1122, 2005.
100. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 83:1325-1358, 2003.
101. Muranyi A, MacDonald JA, Deng JT, Wilson DP, Haystead TA, Walsh MP, Erdodi F, Kiss E, Wu Y, Hartshorne DJ. Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. Biochem J 366:211-216, 2002.
102. Deng JT, Van Lierop JE, Sutherland C, Walsh MP. Ca2+-independent smooth muscle contraction. A novel function for integrin-linked kinase. J Biol Chem 276:16365-16373, 2001.
103. Li L, Eto M, Lee MR, Morita F, Yazawa M, Kitazawa T. Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle. J Physiol 508:871-881, 1998.
104. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273:245-248, 1996.
105. Jin L, Ying Z, Webb RC. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol 287:H1495-H1500, 2004.
106. Koyama M, Ito M, Feng J, Seko T, Shiraki K, Takase K, Hartshorne DJ, Nakano T. Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett 475:197-200, 2000.
107. D'Angelo G, Adam LP. Inhibition of ERK attenuates force development by lowering myosin light chain phosphorylation. Am J Physiol Heart Circ Physiol 282:H602-H610, 2002.
108. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137:481-492, 1997.
109. Kim N, Cao W, Song IS, Kim CY, Harnett KM, Cheng L, Walsh MP, Biancani P. Distinct kinases are involved in contraction of cat esophageal and lower esophageal sphincter smooth muscles. Am J Physiol Cell Physiol 287:C384-C394, 2004.
110. Harnett KM, Biancani P. Calcium-dependent and calcium-independent contractions in smooth muscles. Am J Med 115(Suppl 3A):24S-30S, 2003.
111. Dessy C, Kim I, Sougnez CL, Laporte R, Morgan KG. A role for MAP kinase in differentiated smooth muscle contraction evoked by alpha-adrenoceptor stimulation. Am J Physiol 275:C1081-C1086, 1998.
112. Zhang Y, Moreland S, Moreland RS. Regulation of vascular smooth muscle contraction: myosin light chain phosphorylation dependent and independent pathways. Can J Physiol Pharmacol 72:1386-1391, 1994.
113. Lucchesi PA, Belmadani S, Matrougui K. Hydrogen peroxide acts as both vasodilator and vasoconstrictor in the control of perfused mouse mesenteric resistance arteries. J Hypertens 23:571-579, 2005.
114. Ibitayo AI, Sladick J, Tuteja S, Louis-Jacques O, Yamada H, Groblewski G, Welsh M, Bitar KN. HSP27 in signal transduction and association with contractile proteins in smooth muscle cells. Am J Physiol 277:G445-G454, 1999.
115. Yamboliev IA, Hedges JC, Mutnick JL, Adam LP, Gerthoffer WT. Evidence for modulation of smooth muscle force by the P38 MAP kinase/HSP27 pathway. Am J Physiol Heart Circ Physiol 278:H1899-H1907, 2000.
116. Meloche S, Landry J, Huot J, Houle F, Marceau F, Giasson E. P38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle. Am J Physiol Heart Circ Physiol 279: H741-H751, 2000.
117. Thengchaisri N, Kuo L. Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels. Am J Physiol Heart Circ Physiol 285:H2255-H2263, 2003.
118. Barlow RS, White RE. Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity. Am J Physiol 275:H1283-H1289, 1998.
119. 2 on membrane potential and [Ca2+]i of cultured rat arterial smooth muscle cells. Biochem Biophys Res Commun 209:139-145, 1995.
120. Gao Y-J, Hirota S, Zhang D-W, Janssen LJ, Lee RMKW. Mechanisms of hydrogen-peroxide-induced biphasic response in rat mesenteric artery. Br J Pharmacol 138:1085-1092, 2003.
121. Martens JR, Gelband CH. Ion channels in vascular smooth muscle: alterations in essential hypertension. Proc Soc Exp Biol Med 218:192-203, 1998.
122. Bratz IN, Falcon R, Partridge LD, Kanagy NL. Vascular smooth muscle cell membrane depolarization after NOS inhibition hypertension. Am J Physiol Heart Circ Physiol 282:H1648-H1655, 2002.
123. Martens JR, Gelband CH. Alterations in rat interlobar artery membrane potential and K+ channels in genetic and nongenetic hypertension. Circ Res 79:295-301, 1996.
124. Cox RH, Lozinskaya I, Matsuda K, Dietz NJ. Ramipril treatment alters Ca(2+) and K(+) channels in small mesenteric arteries from Wistar-Kyoto and spontaneously hypertensive rats. Am J Hypertens 15:879-890, 2002.
125. Amberg GC, Bonev AD, Rossow CF, Nelson MT, Santana LF. Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension. J Clin Invest 112:717-724, 2003.
126. Gao YJ, Zhang Y, Hirota S, Janssen LJ, Lee RM. Vascular relaxation response to hydrogen peroxide is impaired in hypertension. Br J Pharmacol 142:143-149, 2004.
127. 2+ and other cellular metabolites. Gen Pharmacol 33:325-336, 1999.
128. Ellis A, Pannirselvam M, Anderson TJ, Triggle CR. Catalase has negligible inhibitory effects on endothelium-dependent relaxations in mouse isolated aorta and small mesenteric artery. Br J Pharmacol 140: 1193-1200, 2003.
129. Zembowicz A, Hatchett RJ, Jakubowski AM, Gryglewski RJ. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta. Br J Pharmacol 110:151-158, 1993.
130. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 290:909-913, 2002.
131. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106:1521-1530, 2000.
132. 2-arachidonic acid signaling cascade in coronary artery smooth muscle. Am J Physiol Heart Circ Physiol 279:H475-H483, 2000.
133. Sato A, Sakuma I, Gutterman DD. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol 285:H2345-H2354, 2003.
134. Iida Y, Katusic ZS. Mechanisms of cerebral arterial relaxations to hydrogen peroxide. Stroke 31:2224-2230, 2000.
135. Burke TM, Wolin MS. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol 252:H721-H732, 1987.
136. Saito T, Ito K, Kurasaki M, Fujimoto S, Kaji H, Saito K. Determination of true specific activity of superoxide dismutase in human erythrocytes. Clin Sci 63:251-255, 1982.
137. 2 in NO-independent relaxations of rabbit arteries. Proc Natl Acad Sci U S A 100:15212-15217, 2003.
138. Hirai T, Tsuru H, Tanimitsu N, Takumida M, Watanabe H, Yajin K, Sasa M. Effect of hydrogen peroxide on guinea pig nasal mucosa vasculature. Jpn J Pharmacol 84:470-473, 2000.
139. 2-induced vascular relaxation by endothelium-derived relaxing factor. Mol Cell Biochem 149-150:267-270, 1995.
140. Fujimoto S, Mori M, Tsushima H. Mechanisms underlying the hydrogen peroxide-induced, endothelium-independent relaxation of the norepinephrine- contraction in guinea-pig aorta. Eur J Pharmacol 459:65-73, 2003.
141. Wei EP, Kontos HA, Beckman JS. Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite. Am J Physiol 271:H1262-H1266, 1996.
142. + channels. Heart Vessels 13:9-17, 1998.
143. Matoba T, Shimokawa H, Morikawa K, Kubota H, Kunihiro I, Urakami-Harasawa L, Mukai Y, Hirakawa Y, Akaike T, Takeshita A. Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels. Arterioscler Thromb Vasc Biol 23:1224-1230, 2003.
144. Yada T, Shimokawa H, Hiramatsu O, Kajita T, Shigeto F, Goto M, Ogasawara Y, Kajiya F. Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo. Circulation 107:1040-1045, 2003.
145. Sofola OA, Knill A, Hainsworth R, Drinkhill M. Change in endothelial function in mesenteric arteries of Sprague-Dawley rats fed a high salt diet. J Physiol 543:255-260, 2002.
146. Sendao Oliveira AP, Bendhack LM. Relaxation induced by acetylcholine involves endothelium-derived hyperpolarizing factor in 2-kidney 1-clip hypertensive rat carotid arteries. Pharmacology 72:231-239, 2004.
147. Cosentino F, Katusic ZS. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91:139-144, 1995.
148. Forgione MA, Cap A, Liao R, Moldovan NI, Eberhardt RT, Lim CC, Jones J, Goldschmidt-Clermont PJ, Loscalzo J. Heterozygous cellular glutathione peroxidase deficiency in the mouse. Abnormalities in vascular and cardiac function and structure. Circulation 106:1154-1158, 2002.
149. Weiss N, Zhang Y-Y, Heydrick S, Bierl C, Loscalzo J. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc Natl Acad Sci U S A 98:12503-12508, 2001.
150. Dayal S, Brown KL, Weydert CJ, Oberley LW, Arning E, Bottiglieri T, Faraci FM, Lentz SR. Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction. Arterioscler Thromb Vasc Biol 22:1996-2002, 2002.
151. Suvorava T, Lauer N, Kumpf S, Jacob R, Meyer W, Kojda G. Endogenous vascular hydrogen peroxide regulates arteriolar tension in vivo. Circulation 112:2487-2495, 2005.
152. Wedgwood S, Black SM. Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 288:L480-L487, 2005.
153. Guikema BJ, Ginnan R, Singer HA, Jourd'heuil D. Catalase potentiates interleukin-1beta-induced expression of nitric oxide synthase in rat vascular smooth muscle cells. Free Radic Biol Med 38:597-605, 2005.
154. Jaimes EA, Sweeney C, Raij L. Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on endothelial nitric oxide production. Hypertension 38:877-883, 2001.
155. Cai H, Li Z, Dikalov S, Holland SM, Hwang J, Jo H, Dudley SC Jr, Harrison DG. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 277:48311-48317, 2002.
156. phox in mice. Am J Physiol Heart Circ Physiol 288:H7-H12, 2005.
157. - levels in rabbit carotid artery. Am J Physiol 277:H2109-H2114, 1999.
158. Bouloumié A, Bauersachs J, Linz W, Schölkens BA, Wiemer G, Fleming I, Busse R. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 30:934-941, 1997.
159. Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun 17:9-20, 1992.
160. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454-456, 1986.
161. Gutierrez JA, Clark SG, Giulumian AD, Fuchs LC. Superoxide anions contribute to impaired regulation of blood pressure by nitric oxide during the development of cardiomyopathy. J Pharmacol Exp Ther 282:1643-1649, 1997.
162. Guzik TJ, West NEJ, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. Vascular superoxide production by NAD(P)H oxidase. Association with endothelial dysfunction and clinical risk factors. Circ Res 86:e85-e90, 2000.
163. Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE, Sessa WC. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 276:17621-17624, 2001.
164. 2-induced O2 production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem 276:29251-29256, 2001.
165. Tampo Y, Kotamraju S, Chitambar CR, Kalivendi SV, Keszler A, Joseph J, Kalyanaraman B. Oxidative stress-induced iron signaling is responsible for peroxide-dependent oxidation of dichlorodihydro-fluorescein in endothelial cells: role of transferrin receptor-dependent iron uptake in apoptosis. Circ Res 92:56-63, 2003.
166. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91:21-27, 2000.
167. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski H, Halleran S, Alexander RW. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21:489-495, 2001.
168. Heeneman S, Haendeler J, Saito Y, Ishida M, Berk BC. Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor β receptor. Key role for the P66 adaptor protein Shc. J Biol Chem 275:15926-15932, 2000.
169. Silver MA, Pick R, Brilla CG, Jalil JE, Janicki JS, Weber KT. Reactive and reparative fibrillar collagen remodelling in the hypertrophied left ventricle: two experimental models of myocardial fibrosis. Cardiovasc Res 24:741-747, 1990.
170. Yoshizumi M, Abe J, Haendeler J, Huang Q, Berk BC. Src and Cas mediate JNK activation but not ERK1/2 and P38 kinases by reactive oxygen species. J Biol Chem 275:11706-11712, 2000.
171. Abe J, Kusuhara M, Ulevitch RJ, Berk BC, Lee J-D. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem 271:16586-16590, 1996.
172. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. P38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273:15022-15029, 1998.
173. Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kübler W, Kreuzer J. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II. Involvement of P22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 20:940-948, 2000.
174. - in vascular smooth muscle cells. Circ Res 77:29-36, 1995.
175. 2-induced activation of ERK1/2, P38 MAPK, and protein kinase B signaling in vascular smooth muscle cells. Antioxid Redox Signal 6:353-366, 2004.
176. Frank GD, Eguchi S, Yamakawa T, Tanaka S, Inagami T, Motley ED. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. Endocrinology 141:3120-3126, 2000.
177. 2 regulates the activation of distinct MAPK pathways. Free Radic Biol Med 33:1121-1132, 2002.
178. Touyz RM, Deschepper C, Park JB, He G, Chen X, Neves MFT, Virdis A, Schiffrin EL. Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats. J Hypertens 20:1127-1134, 2002.
179. Matrougui K, Eskildsen-Helmond YEG, Fiebeler A, Henrion D, Levy BI, Tedgui A, Mulvany MJ. Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric resistance arteries. Hypertension 36:617-621, 2000.
180. Massett M., Ungvari Z, Csiszar A, Kaley G, Koller A. Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists. Am J Physiol Heart Circ Physiol 283:H2282-H2287, 2002.
181. Watts SW, Florian JA, Monroe KM. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction. J Pharmacol Exp Ther 286:1431-1438, 1998.
182. Banes AKL, Loberg RD, Brosius FC III, Watts SW. Inability of serotonin to activate the C-Jun N-terminal kinase and P38 kinase pathways in rat aortic vascular smooth muscle cells. BMC Pharmacol 1:8, 2001.
183. Watts SW. Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase kinase inhibitor PD098059. J Pharmacol Exp Ther 279:1541-1550, 1996.
184. Ohanian J, Cunliffe P, Ceppi E, Alder A, Heerkens E, Ohanian V. Activation of P38 mitogen-activated protein kinases by endothelin and noradrenaline in small arteries, regulation by calcium influx and tyrosine kinases, and their role in contraction. Arterioscler Thromb Vasc Biol 21:1921-1927, 2001.
185. Kwon S, Fang LH, Kim B, Ha TS, Lee SJ, Ahn HY. P38 mitogen-activated protein kinase regulates vasoconstriction in spontaneously hypertensive rats. J Pharmacol Sci 95:267-272, 2004.
186. Northcott CA, Poy MN, Najjar SM, Watts SW. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circ Res 91:360-369, 2002.
187. Swärd K, Mita M, Wilson DP, Deng JT, Susnjar M, Walsh MP. The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction. Curr Hypertens Rep 5:66-72, 2003.
188. Rey RE, Pagano PJ. The reactive adventitia. Fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol 22:1962-1971, 2002.
189. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 32:488-495, 1998.
190. Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62:749-756, 1998.
191. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17:626-635, 1991.
192. Wolin MS. Reactive oxygen species and vascular signal transduction mechanisms. Microcirculation 3:1-17, 1996.
193. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 274:22699-22704, 1999.
194. 2. Hypertension 46:732-737, 2005.
195. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 88:947-953, 2001.
196. Liu J, Ormsby A, Oja-Tebbe N, Pagano PJ. Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy. Circ Res 95:587-594, 2004.
197. Bush E, Maeda N, Kuziel WA, Dawson TC, Wilcox JN, DeLeon H, Taylor WR. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension 36:360-363, 2000.
198. Janabi M, Yamashita S, Hirano K, Matsumoto K, Nozaki S, Matsuzawa Y. Reduced secretion of tumor necrosis factor-α and interleukin-1β from monocyte-derived macrophages of CD36-deficient subjects in response to oxidized LDL. In: Kita T, Yokode M, Eds. Lipoprotein Metabolism and Atherogenesis. Tokyo: Springer-Verlag, pp227-229, 2000.
199. Kiarash A, Carretero OA, Pagano PJ. A competitive inhibitor of NADPH oxidase reduces ICAM-1 expression and macrophage infiltration in the rat thoracic aorta (abstract). Free Radic Biol Med 29(Suppl 1):S48, 2000.
200. Liu J, Yang F, Yang X-P, Jankowski M, Pagano PJ. NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler Thromb Vasc Biol 23:776-782, 2003.
201. Dourron HM, Jacobson GM, Park JL, Liu J, Reddy DJ, Scheel ML, Pagano PJ. Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery. Am J Physiol Heart Circ Physiol 288:H946-H953, 2005.
202. Wang HD, Johns DG, Xu S, Cohen RA. Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II. Am J Physiol Heart Circ Physiol 282:H1697-H1702, 2002.
203. phox in human coronary arteries. Circulation 100:1494-1498, 1999.
204. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546-2551, 1993.
205. Shi Y, Niculescu R, Wang D, Patel S, Davenpeck KL, Zalewski A. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol 21:739-745, 2001.
206. Szöcs K, Lassègue B, Sorescu D, Hilenski LL, Valppu L, Couse TL, Wilcox JN, Quinn MT, Lambeth JD, Griendling KK. Upregulation of nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 22:21-27, 2002.